eLetters is an online forum for ongoing peer review. Submission of eLetters are open to all. Please read our Terms of Service before submitting your own eLetter.
Research ArticleInfectious Disease
A highly potent extended half-life antibody as a potential RSV vaccine surrogate for all infants
- View ORCID ProfileQing Zhu1,*,†,
- View ORCID ProfileJason S. McLellan2,†,
- View ORCID ProfileNicole L. Kallewaard1,
- View ORCID ProfileNancy D. Ulbrandt1,
- Susan Palaszynski1,
- Jing Zhang1,
- Brian Moldt1,
- Anis Khan3,
- View ORCID ProfileCatherine Svabek1,
- View ORCID ProfileJosephine M. McAuliffe1,
- Daniel Wrapp2,
- View ORCID ProfileNita K. Patel1,
- Kimberly E. Cook4,
- Bettina W. M. Richter1,
- Patricia C. Ryan5,
- View ORCID ProfileAndy Q. Yuan4 and
- View ORCID ProfileJoAnn A. Suzich1,*
- 1Department of Infectious Disease, MedImmune LLC, One MedImmune Way, Gaithersburg, MD 20878, USA.
- 2Department of Biochemistry and Cell Biology, Geisel School of Medicine at Dartmouth, 7200 Vail Building, Hanover, NH 03755, USA.
- 3Department of Clinical Pharmacology and Drug Metabolism and Pharmacokinetics, MedImmune LLC, One MedImmune Way, Gaithersburg, MD 20878, USA.
- 4Department of Antibody Discovery and Protein Engineering, MedImmune LLC, One MedImmune Way, Gaithersburg, MD 20878, USA.
- 5Biologics Safety Assessment, MedImmune LLC, One MedImmune Way, Gaithersburg, MD 20878, USA.
- ↵*Corresponding author. Email: suzichj{at}medimmune.com (J.A.S.); zhuq{at}medimmune.com (Q.Z.)
↵† These authors contributed equally to this work.
See allHide authors and affiliations
Science Translational Medicine 03 May 2017:
Vol. 9, Issue 388, eaaj1928
DOI: 10.1126/scitranslmed.aaj1928
Vol. 9, Issue 388, eaaj1928
DOI: 10.1126/scitranslmed.aaj1928
Qing Zhu
1Department of Infectious Disease, MedImmune LLC, One MedImmune Way, Gaithersburg, MD 20878, USA.
Jason S. McLellan
2Department of Biochemistry and Cell Biology, Geisel School of Medicine at Dartmouth, 7200 Vail Building, Hanover, NH 03755, USA.
Nicole L. Kallewaard
1Department of Infectious Disease, MedImmune LLC, One MedImmune Way, Gaithersburg, MD 20878, USA.
Nancy D. Ulbrandt
1Department of Infectious Disease, MedImmune LLC, One MedImmune Way, Gaithersburg, MD 20878, USA.
Susan Palaszynski
1Department of Infectious Disease, MedImmune LLC, One MedImmune Way, Gaithersburg, MD 20878, USA.
Jing Zhang
1Department of Infectious Disease, MedImmune LLC, One MedImmune Way, Gaithersburg, MD 20878, USA.
Brian Moldt
1Department of Infectious Disease, MedImmune LLC, One MedImmune Way, Gaithersburg, MD 20878, USA.
Anis Khan
3Department of Clinical Pharmacology and Drug Metabolism and Pharmacokinetics, MedImmune LLC, One MedImmune Way, Gaithersburg, MD 20878, USA.
Catherine Svabek
1Department of Infectious Disease, MedImmune LLC, One MedImmune Way, Gaithersburg, MD 20878, USA.
Josephine M. McAuliffe
1Department of Infectious Disease, MedImmune LLC, One MedImmune Way, Gaithersburg, MD 20878, USA.
Daniel Wrapp
2Department of Biochemistry and Cell Biology, Geisel School of Medicine at Dartmouth, 7200 Vail Building, Hanover, NH 03755, USA.
Nita K. Patel
1Department of Infectious Disease, MedImmune LLC, One MedImmune Way, Gaithersburg, MD 20878, USA.
Kimberly E. Cook
4Department of Antibody Discovery and Protein Engineering, MedImmune LLC, One MedImmune Way, Gaithersburg, MD 20878, USA.
Bettina W. M. Richter
1Department of Infectious Disease, MedImmune LLC, One MedImmune Way, Gaithersburg, MD 20878, USA.
Patricia C. Ryan
5Biologics Safety Assessment, MedImmune LLC, One MedImmune Way, Gaithersburg, MD 20878, USA.
Andy Q. Yuan
4Department of Antibody Discovery and Protein Engineering, MedImmune LLC, One MedImmune Way, Gaithersburg, MD 20878, USA.
JoAnn A. Suzich
1Department of Infectious Disease, MedImmune LLC, One MedImmune Way, Gaithersburg, MD 20878, USA.
Submit a Response to This Article
No eLetters have been published for this article.